(PBUS) Invesco PureBeta MSCI USA - Ratings and Ratios
Exchange: BATS • Country: USA • Currency: USD • Type: Etf • ISIN: US46138E4614
PBUS: Large Cap Stocks, Mid Cap Stocks
The Invesco PureBeta MSCI USA ETF (BATS:PBUS) is designed to track the performance of the large- and mid-capitalization segments of the U.S. equity market, with a minimum of 90% of its total assets invested in the underlying index securities. The index is compiled and maintained by MSCI Inc., adhering to strict guidelines and procedures.
As a non-diversified ETF, PBUS is more concentrated in its holdings, which can result in higher volatility. The funds focus on large- and mid-cap U.S. equities positions it for potential long-term growth, given the historical performance of these market segments.
Analyzing the technical data, the current price of $60.26 is above both the 20-day SMA ($59.18) and 50-day SMA ($56.35), indicating a positive short-term trend. The 200-day SMA ($57.78) is also below the current price, suggesting a longer-term uptrend. The Average True Range (ATR) of 0.74 (1.23%) indicates moderate volatility. Considering the 52-week high ($61.52) and low ($49.79), the current price is near the upper end of the range, potentially indicating a slight overbought condition.
From a fundamental perspective, the funds Assets Under Management (AUM) stand at $7.078 billion, indicating a sizable presence in the market. This scale can contribute to lower expense ratios and increased liquidity.
Forecasting future performance, we can anticipate that if the current uptrend continues, PBUS may challenge its 52-week high of $61.52. Conversely, a downturn could see the price retreating to the 50-day SMA ($56.35) or lower. Given the funds tracking of the large- and mid-cap U.S. equity market, its performance will be closely tied to overall market conditions. If the U.S. equity market continues to grow, driven by economic expansion or other factors, PBUS is likely to benefit, potentially outperforming in a strong market environment. However, its non-diversified nature means it may be more susceptible to downturns in specific sectors or stocks that comprise a significant portion of the index.
Additional Sources for PBUS ETF
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle
PBUS ETF Overview
Market Cap in USD | 7,078m |
Category | Large Blend |
TER | 0.04% |
IPO / Inception | 2017-09-22 |
PBUS ETF Ratings
Growth Rating | 71.2 |
Fundamental | - |
Dividend Rating | 56.7 |
Rel. Strength | 0.48 |
Analysts | - |
Fair Price Momentum | 59.10 USD |
Fair Price DCF | - |
PBUS Dividends
Dividend Yield 12m | 1.23% |
Yield on Cost 5y | 2.52% |
Annual Growth 5y | 6.40% |
Payout Consistency | 96.2% |
Payout Ratio | % |
PBUS Growth Ratios
Growth Correlation 3m | 69.8% |
Growth Correlation 12m | 44.9% |
Growth Correlation 5y | 81.3% |
CAGR 5y | 15.97% |
CAGR/Max DD 5y | 0.63 |
Sharpe Ratio 12m | 1.60 |
Alpha | 0.48 |
Beta | 1.007 |
Volatility | 10.94% |
Current Volume | 155.4k |
Average Volume 20d | 62.6k |
As of June 15, 2025, the stock is trading at USD 59.99 with a total of 155,422 shares traded.
Over the past week, the price has changed by -0.45%, over one month by +1.68%, over three months by +8.86% and over the past year by +11.99%.
Yes. Based on ValueRay´s Analyses, Invesco PureBeta MSCI USA (BATS:PBUS) is currently (June 2025) a good stock to buy. It has a ValueRay Growth Rating of 71.22 and therefor a clear technical positive rating according to historical growth.
Based on momentum, paid dividends and discounted-cash-flow analyses, the fair value of PBUS is around 59.10 USD . This means that PBUS is currently overvalued and has a potential downside of -1.48%.
Invesco PureBeta MSCI USA has no consensus analysts rating.
According to our own proprietary Forecast Model, PBUS Invesco PureBeta MSCI USA will be worth about 67.6 in June 2026. The stock is currently trading at 59.99. This means that the stock has a potential upside of +12.72%.
Issuer | Target | Up/Down from current |
---|---|---|
Wallstreet Target Price | - | - |
Analysts Target Price | - | - |
ValueRay Target Price | 67.6 | 12.7% |